Observational study / 2025
Beni-koji (red yeast rice) tablet use was linked to Fanconi syndrome and persistent kidney dysfunction in a nationwide Japanese survey.
A two-phase nationwide survey of Japanese nephrologists investigated 192 patients with kidney injury associated with specific Beni-koji tablets. At presentation, 94.1% had an eGFR below 60 ml/min/1.73m2, alongside features of Fanconi syndrome such as hypokalemia, hypophosphatemia, hypouricemia, glycosuria, and metabolic acidosis. Kidney biopsies showed predominant tubulointerstitial changes, including tubulointerstitial nephritis in 50% and tubular necrosis in 32%. Following product discontinuation and treatment, Fanconi syndrome parameters improved significantly, but 87% of patients still had an eGFR under 60 ml/min/1.73m2 at the last observation.
Shows an association, not proof of cause and effect.
- Study type
- Two-phase nationwide questionnaire survey
- Who was studied
- 192 patients with kidney injury associated with Beni-koji tablets in Japan
- What was measured
- Clinical, laboratory, and pathological features, and eGFR trajectories
THE PAPER
A nationwide questionnaire study evaluated kidney injury associated with Beni-koji tablets in Japan.
Shinzawa M, Matsui I, Doi Y, Matsumoto A, Takahashi A, Nangaku M, Isaka Y, Collaborators. Kidney Int, 2025.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.